Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years

Panagiotis Tsikouras, Efthymios Oikonomou, Georgios Tsatsaris, Anastasia Bothou, Αnastasia Bothou, Dimitrios Kyriakou, Konstantinos Nikolettos, Theopi Nalmbanti, Panagiotis Peitsidis, Grigorios Trypsanis, Grigorios Trypsiannis, Georgios Iatrakis, Nikolaos Nikolettos, Vasileios Souftas
Journal of personalized medicine · 2023 · vol. 13(9) , pp. 1385 · doi:10.3390/jpm13091385 · PMID:37763151 · W4386814443
article OA: gold CC0 ⤵ 4 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

Abstract

Uterine artery embolization (UAE) for the treatment of symptomatic uterine fibroids and non-controllable adenomyosis symptoms is a relatively new procedure for organ-preserving therapy. These benign conditions can become symptomatic in about 30% of women between the ages of 35 and 50. The purpose of the UAE either for fibroids or adenomyosis is the elimination of blood loss, the reduction in pain, and bulky or rectal pressure symptoms. The purpose of this study is to present our experience in UAE with the use of hydrogel-coated tris acryl microspheres for the treatment of symptomatic uterine fibroids and adenomyosis.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (4)

References (41)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-06-01T00:33:21.814408+00:00
License: CC0 · commercial use OK